Edition:
India

Profile: IPCA Laboratories Ltd (IPCA.BO)

IPCA.BO on Bombay Stock Exchange

489.35INR
2:59pm IST
Change (% chg)

Rs2.15 (+0.44%)
Prev Close
Rs487.20
Open
Rs487.20
Day's High
Rs490.85
Day's Low
Rs486.75
Volume
11,227
Avg. Vol
71,078
52-wk High
Rs888.00
52-wk Low
Rs402.00

Ipca Laboratories Ltd. is an India-based pharmaceutical company. The Company's formulations business in India consists of 13 marketing divisions focusing on therapeutic segments, including non-steroidal anti-inflammatory drugs (NSAID), cardiovascular and anti-diabetics, anti-malarial, anti-bacterial, gastro intestinal (GI) products, cough preparations, dermatology, neuro psychiatry, urology, neutraceutical and others. The Company manufactures over 350 formulations and 80 active pharmaceutical ingredients (API). The Company also offers Disease Modifying Anti-Rheumatic Drugs treatment for rheumatoid arthritis. The Company exports its APIs to the United States, Canada, Brazil, Mexico and generic formulations to the United States, Canada and branded formulations to Panama, West Indies, Venezuela, Peru and Colombia in this sub-continent.

Company Address

IPCA Laboratories Ltd

142 AB, Kandivli Industrial Esta
Kandivli (West)
MUMBAI     400067
P: +9122.66474747
F: +9122.28686954

Company Web Links